Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Positive phase II results with RMP-7/carboplatin

Dec. 19, 1996

Prostate cancer gene therapy trial commences

Dec. 19, 1996

Antineoplastic anthracycline antibiotic disclosed by Mercian

Dec. 19, 1996

Mercian reports new antitumor anthracycline

Dec. 19, 1996

Chemopreventive effects of Targretin in breast cancer

Dec. 18, 1996

Mercian discloses novel antitumor anthracycline antibiotics

Dec. 18, 1996

Antiangiogenic compounds described by Taiho

Dec. 18, 1996

CAK1 gene for treatment and diagnosis of cancers available for licensing

Dec. 17, 1996

SuperGen licenses metalloorganic compounds

Dec. 17, 1996

Angiogenesis inhibitors under study at ADIR

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...